NIDDK Seeks Applicants to Expand Drug Induced Liver Injury Network | GenomeWeb
NEW YORK (GenomeWeb News) – The National Institute of Diabetes and Digestive and Kidney Diseases plans this fall to issue RFAs that will extend a program it started in 2003 that uses various genomics methods to study liver diseases caused by adverse drug reactions.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.